Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you recommend hypofractionated PMRT with a positive deep margin?
How would you dose?
Answer from: Radiation Oncologist at Community Practice
I have used hypofractionated RT in this setting with final boost to area of positive margin equivalent to 60 Gy
Comments
Radiation Oncologist at Charlotte Hungerford Hospital
Thank you!
Radiation Oncologist at Bismarck Cancer Center
I agree, with a caveat - if the pathology report d...
Radiation Oncologist at Mallory Radiotherapy, PLLC
Dr. @Beriwal, what bolus regimen for the primary a...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
If it’s a deep margin, then may avoid bolus ...
1396
1399
13525
13535
Sign in or Register to read more
5215
Related Questions
What are your top takeaways in Breast Cancer from ASTRO 2024?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
Are there additional risks associated with PMRT for a patient with prior lympho-venous bypass surgery?
Would you consider once weekly radiation with a simultaneous integrated boost for a patient with node negative breast cancer with a positive margin for whom reexcision is not an option?
Would you feel comfortable doing high tangents with ultra-hypofractionation?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
In a patient with T2N0 breast cancer with skin involvement s/p lumpectomy and negative margins, if you are offering whole breast radiation, would you bolus your tangent fields?
Thank you!
I agree, with a caveat - if the pathology report d...
Dr. @Beriwal, what bolus regimen for the primary a...
If it’s a deep margin, then may avoid bolus ...